If you’re working in market access, the time has come to seize the opportunity. With our healthcare system is living on borrowed time, we must build a new value-based healthcare model that’s fit for purpose, encouraging the development of treatments that push scientific boundaries and ensuring that patients will have affordable access.

Only at the Market Access USA Conference and will you see how your competitors have proactively engaged with payers, providers, patients and even competitors to create the new system that creates value for all.

When you download the agenda, you will find sessions from medical affairs leaders from Merck, Janssen, BMS and EMD Serono on how to:

  • Collaborate to innovate – engage payers, providers and patients to develop a system that benefits all

  • The value-based blueprint –speed up negotiations and engage payer needs with the essential framework for value-based contracts

  • Affordability first – develop innovative payment solutions that provide affordable access to life-changing treatments
  • More evidence = earlier access – how RWE can unlock phase 2 access

Fill in your details now to see the full agenda and speaker line-up >>>

Give all stakeholders value, or lose ground

eyeforpharma Ltd, headquartered at 7-9 Fashion Street, London, E1 6PX, United Kingdom. A registered company in England and Wales: 09823909.

Terms and conditions | Privacy Policy

Josh Bramwell
Global Project Director
Phone: +44 (0) 207 375 7203
Email: jbramwell@eyeforpharma.com

Benchmark your strategies against the industry’s best at the Market Access USA Conference at eyeforpharma Philadelphia 2019

Fill in your details below to access the agenda and full speaker line up.